Intraoperative and postoperative blood loss in total hip arthroplasty.
Conditions
Interventions
Intervention 1: Intervention group: Patients receiving clonidine tablet. Intervention 2: Control group: Patients receiving placebo tablet.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: ASA class 1 and 2 patients Elective total hip arthroplasty Primary total hip arthroplasty
Exclusion criteria
Exclusion criteria: ASA 3 and 4 patients Patients with BMI greater than 30 Patients with Hb less than 10 Patients with severe liver or kidney diseases Patients taking anticoagulants patients with coagulation disorders Alcoholic patients Revision total hip arthroplasty Patients with previous surgery in the operated area
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of bleeding during the operation. Timepoint: After intervention during surgery. Method of measurement: Weighing blood gases, amount of blood in the suction bottle, blood in the operative site. | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative hemoglobin level. Timepoint: On the first and third day after surgery. Method of measurement: Measured from a blood sample.;Blood transfusion rate. Timepoint: During surgery and in the postoperative period. Method of measurement: Number of transfused units of blood. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShideh dabir
Shahid Beheshti University of Medical Sciences
Outcome results
None listed